Continuing Education (CE) and Continuing Nurse Education (CNE) Activities

Credits: 1.00 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Personalizing Disease-Modifying Therapy for Multiple Sclerosis in the Era of Expanding Treatment Options and Potential Biomarkers
2 July, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Mapping Progress With Immune Checkpoint Inhibitors in Head and Neck Cancer: Expert Views on Immunotherapy as a Component of Multimodal Care
Ezra Cohen, MD, FRCPSC, FASCO
2 July, 2019
Credits: 1.00 CME / CNE / CPE
Medical Learning Institute, Inc.
Beyond the Basics of Immuno-Oncology: Navigating Clinical Challenges to Maximize the Benefits and Minimize the Risks of Cancer Immunotherapies
Evan J. Lipson, MD
26 June, 2019
Credits: 0.50 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
Robert D. McBane, MD
25 June, 2019
Credits: 1.00 CME / CNE / CPE
Penn State College of Medicine / Medical Learning Institute, Inc.
The Emergence of Oral Therapy as a Pillar of Care in B-Cell Lymphoma: Insights and Expert Opinions From the Hematology-Oncology Team
Nathan H. Fowler, MD
21 June, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
The Expanding Role of Immunotherapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Thoracic Surgeons
Jessica Donington, MD
17 June, 2019
Credits: 1.25 CME / MOC / CNE
Medical Learning Institute, Inc.
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Elizabeth A. Mittendorf, MD, PhD
3 June, 2019
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
A New Era Has Begun in the Treatment of SCLC: Navigating Novel Therapeutic Options and Strategies for Improving Patient Outcomes
Stephen V. Liu, MD
29 May, 2019
Credits: 1.50 CNE
Medical Learning Institute, Inc.
Navigating the CAR-T Cell Therapy Landscape in Hematologic Malignancies: Science and Practical Issues in Nursing Care
Susan Blumel, RN, BSN
24 May, 2019
Credits: 1.50 CNE
Medical Learning Institute, Inc.
Clinical Advances in Pancreatic Cancer: The Oncology Nurse as a Leader and Advocate for Patients in a Changing Therapeutic Landscape
Gayle Jameson, MSN, ACNP-BC, AOCN
22 May, 2019
Credits: 1.50 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
An Oncology Nurse MasterClass on Oral Therapy in B-Cell Malignancies: Insights on Evidence, Practical Strategies, and the Nurse-Patient Partnership
Barbara Barnes Rogers, CRNP, MN, AOCN, ANP-BC
22 May, 2019
Credits: 1.50 CNE
Medical Learning Institute, Inc.
Realizing the Promise of PARP Inhibitors in Solid Tumor Therapy: Guiding Oncology Nurses on the Advances and Challenges
Kimberly Halla, MSN, FNP-C
21 May, 2019
Credits: 1.50 CNE / CE
Medical Learning Institute, Inc.
Taking Aim at B-Cell Malignancies With BTK Inhibitors: Oncology Nurse Perspectives and Insights on Clinical Care
Mollie Moran, APRN-CNP, AOCNP
16 May, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
The Present and Future of Immunotherapy as a Key Component of the Treatment Arsenal for Locally Advanced & Earlier Stages of Lung Cancer
Leora Horn, MD, MSc, FRCPC
9 May, 2019
Credits: 1.50 CME / CNE
Penn State College of Medicine
BTK Inhibition as an Anti-Cancer Strategy: Exploring a Model for Modern Targeted Therapy in Hematologic Malignancies and Beyond
John C. Byrd, MD
6 May, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine / Medical Learning Institute, Inc.
Oncology Nurse Insights Into New Agent Classes and Research in B-Cell Lymphoma: Practical Issues and Evidence for the Front-Lines of Care
Amy Goodrich, NP
30 April, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
New Frontiers in Precision Immuno-Oncology: Leveraging Biomarkers to Refine and Expand the Use of Cancer Immunotherapies and Combinations
Justin Gainor, MD
26 April, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Refining Current Practice and Exploring New Frontiers in EGFR-Mutant NSCLC: Evolving Science, New Standards of Care, and Implications for Multidisciplinary Management
Benjamin Levy, MD
17 April, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Addressing Unmet Needs in Earlier Stages of NSCLC With Immunotherapy: Cutting-Edge Research, Clinical Applications, and Practical Challenges
Scott Antonia, MD, PhD
15 April, 2019
Credits: 0.75 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Advances in the Management of Allergic and Inflammatory Diseases: Highlights From Washington, DC and San Francisco
Jonathan Corren, MD / Paul Yamauchi, MD
12 April, 2019

Pages